Get to know Cymabay better with 10+ real example sentences.
Cymabay in a sentence
Using Cymabay
- In the example corpus, cymabay often appears in combinations such as: cymabay therapeutics, of cymabay, in cymabay.
Context around Cymabay
- Average sentence length in these examples: 19.6 words
- Position in the sentence: 2 start, 8 middle, 0 end
- Sentence types: 10 statements, 0 questions, 0 exclamations
Corpus analysis for Cymabay
- In this selection, "cymabay" usually appears in the middle of the sentence. The average example has 19.6 words, and this corpus slice is mostly made up of statements.
- Around the word, therapeutics stand out and add context to how "cymabay" is used.
- Recognizable usage signals include shares of cymabay therapeutics by and anticipate that cymabay therapeutics will. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "cymabay" sits close to words such as aab, aamer and aave, which helps place it inside the broader word index.
Example types with cymabay
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
BlackRock Inc. increased its position in shares of CymaBay Therapeutics by 12.6% in the fourth quarter. (17 words)
CM Management LLC raised its position in shares of CymaBay Therapeutics by 60.0% during the fourth quarter. (18 words)
Certain Stock Options of CymaBay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2023. (19 words)
Also, General Counsel Paul T. Quinlan sold 5,000 shares of CymaBay Therapeutics stock in a transaction that occurred on Monday, October 16th. (23 words)
CymaBay Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. (21 words)
As a group, research analysts anticipate that CymaBay Therapeutics will post -0.93 earnings per share for the current year. (20 words)
Example sentences (10)
Also, General Counsel Paul T. Quinlan sold 5,000 shares of CymaBay Therapeutics stock in a transaction that occurred on Monday, October 16th.
As a group, research analysts anticipate that CymaBay Therapeutics will post -0.93 earnings per share for the current year.
California State Teachers Retirement System bought a new stake in CymaBay Therapeutics in the first quarter valued at $649,000.
Certain Stock Options of CymaBay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2023.
CM Management LLC raised its position in shares of CymaBay Therapeutics by 60.0% during the fourth quarter.
Finally, CTC Capital Management LLC bought a new position in CymaBay Therapeutics during the first quarter valued at $93,000.
China Universal Asset Management Co. Ltd. increased its holdings in CymaBay Therapeutics by 96.9% during the 3rd quarter.
William Blair restated an “outperform” rating on shares of CymaBay Therapeutics in a research report on Tuesday, November 14th.
BlackRock Inc. increased its position in shares of CymaBay Therapeutics by 12.6% in the fourth quarter.
CymaBay Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases.
Common combinations with cymabay
These word pairs occur most frequently in English texts:
- cymabay therapeutics 11×
- of cymabay 5×
- in cymabay 3×